Fingerprint
Dive into the research topics of 'A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically